HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HYPR

Hyperfine, Inc.

Healthcare — Medical Devices

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

None 3 analysts
$0.87
+$0.06 (+7.88%)
Target: $2.17 (148.6%)

Price History

52-Week Range
Sign in to add HYPR to a watchlist or set price alerts.

Fundamentals

Market Cap$92.90M
P/E Ratio (TTM)-
Forward P/E-2.75
EPS (TTM)$-0.40
Dividend Yield-
Profit Margin-226.88%
Revenue Growth82.60%
ROE-89.78%
Debt/Equity38.91
Recommendation None
Analyst Target$2.17
Analysts3
Next Earnings Aug 6, 2026 AMC
Indexes -

Technical Indicators

RSI (14)33.1
Beta1.40
SMA 20$1.02
SMA 40$1.22
52-Week High$2.22
52-Week Low$0.85
50-Day Avg$1.29
200-Day Avg$1.22
Avg Volume$1.00M
Volume895.9K

Performance Analysis

NEUTRAL

HYPR presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($0.85), which could present a value opportunity.
~ RSI at 33.1 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 82.6% year-over-year.
- Operating at a loss with -226.9% margin.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $2.17 implies 148.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:14 UTC

Back to Screener Export Report